抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
JW74，≥99%(HPLC) | C24H20N6O2S | |||
|
|
|||||
|
Dimethylenastron，98% | C20H30O | |||
|
|
|||||
|
Mafodotin，98% | C49H76N6O11 | |||
|
|
|||||
|
Mc-MMAE，97% | C49H78N6O10 | |||
|
|
|||||
|
TRC051384，97% | C25H31N5O4 | |||
|
|
|||||
|
AKTI-2008，99% | C33H29N7O | |||
|
|
|||||
|
ATN-161 (trifluoroacetate salt)，95% | C25H36F3N9O10S | |||
|
|
|||||
|
Litronesib（LY-2523355; KF-89617），99% | C23H37N5O4S2 | |||
|
|
|||||
|
GAP-134 (Hydrochloride)，99% | C14H18ClN3O4 | |||
|
|
|||||
|
|
BNC105，98% | C20H20O7 | |||
|
|
|||||
|
SNX-2112 (PF-04928473)，98% | C23H27F3N4O3 | |||
|
|
|||||
|
Recilisib sodium，98% | C16H12ClNaO4S | |||
|
|
|||||
|
GSK2141795，99% | C18H16Cl2F2N4O2 | |||
|
|
|||||
|
AZ 3146，99% | C24H32N6O3 | |||
|
|
|||||
|
IWR-1-endo，99% | C25H19N3O3 | |||
|
|
|||||
|
FRAX597，≥98%(HPLC) | C29H28ClN7OS | |||
|
|
|||||
|
Mertansine，98% | C35H48ClN3O10S | |||
|
|
|||||
|
|
CW 069，98% | C23H21IN2O3 | |||
|
|
|||||
|
|
Cyclo(-Arg-Gly-Asp-D-Phe-Lys)，98% | C27H41N9O7 | |||
|
|
|||||
|
KYA1797K，98% | C17H11KN2O6S2 | |||
|
|
|||||
|
KNK437，98% | C13H11NO4 | |||
|
|
|||||
|
SC79，98% | C17H17ClN2O5 | |||
|
|
|||||
|
IQ-1，98% | C21H22N4O2 | |||
|
|
|||||
|
|
Pamidronic Acid See P172500，98% | C3H11NO7P2 | |||
|
|
|||||
|
|
CK-636，98% | C16H16N2OS | |||
|
|
|||||
|
LF3，98% | C20H24N4O2S2 | |||
|
|
|||||
|
Ansamitocin P-3，98% | C32H43ClN2O9 | |||
|
|
|||||
|
IWP-2，97% | C22H18N4O2S3 | |||
|
|
|||||
|
ISX-9 (Isoxazole 9)，99% | C11H10N2O2S | |||
|
|
|||||
